165 related articles for article (PubMed ID: 16039711)
21. Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation.
Kim SK; Vaishali B; Lee E; Lee S; Lee YK; Kumar TS; Moon HT; Byun Y
Thromb Res; 2006; 117(4):419-27. PubMed ID: 15913716
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.
Lee YK; Kim SK; Lee DY; Lee S; Kim CY; Shin HC; Moon HT; Byun Y
J Control Release; 2006 Apr; 111(3):290-8. PubMed ID: 16497407
[TBL] [Abstract][Full Text] [Related]
23. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
Blatný J; Fiamoli V
Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
[TBL] [Abstract][Full Text] [Related]
24. Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin.
Yang T; Hussain A; Bai S; Khalil IA; Harashima H; Ahsan F
J Control Release; 2006 Oct; 115(3):289-97. PubMed ID: 17023085
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo investigation of low molecular weight heparin-alginate beads for oral administration.
Iskenderoğlu C; Acartürk F; Erdoğan D; Bardakçi Y
J Drug Target; 2013 May; 21(4):389-406. PubMed ID: 23350807
[TBL] [Abstract][Full Text] [Related]
26. Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin.
Hayes PY; Ross BP; Thomas BG; Toth I
Bioorg Med Chem; 2006 Jan; 14(1):143-52. PubMed ID: 16169233
[TBL] [Abstract][Full Text] [Related]
27. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction.
Sinico C; Manconi M; Peppi M; Lai F; Valenti D; Fadda AM
J Control Release; 2005 Mar; 103(1):123-36. PubMed ID: 15710506
[TBL] [Abstract][Full Text] [Related]
28. Can drug-bearing liposomes penetrate intact skin?
El Maghraby GM; Williams AC; Barry BW
J Pharm Pharmacol; 2006 Apr; 58(4):415-29. PubMed ID: 16597359
[TBL] [Abstract][Full Text] [Related]
29. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
Mura S; Manconi M; Sinico C; Valenti D; Fadda AM
Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377
[TBL] [Abstract][Full Text] [Related]
30. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
31. Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study.
Bai S; Gupta V; Ahsan F
Eur J Pharm Sci; 2009 Sep; 38(2):165-71. PubMed ID: 19616095
[TBL] [Abstract][Full Text] [Related]
32. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
33. Influence of nanosized delivery systems with benzyl nicotinate and penetration enhancers on skin oxygenation.
Abramović Z; Sustarsic U; Teskac K; Sentjurc M; Kristl J
Int J Pharm; 2008 Jul; 359(1-2):220-7. PubMed ID: 18472233
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
Fiore MM; Mackie IM
Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
[TBL] [Abstract][Full Text] [Related]
35. Effect of subconjunctivally injected, liposome-bound, low-molecular-weight heparin on the absorption rate of subconjunctival hemorrhage in rabbits.
Moon JW; Song YK; Jee JP; Kim CK; Choung HK; Hwang JM
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3968-74. PubMed ID: 16936112
[TBL] [Abstract][Full Text] [Related]
36. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.
Abildgaard U; Sandset PM; Hammerstrøm J; Gjestvang FT; Tveit A
Thromb Res; 2009 Jul; 124(3):262-7. PubMed ID: 19162303
[TBL] [Abstract][Full Text] [Related]
37. Heparin and low-molecular-weight heparin.
Gray E; Mulloy B; Barrowcliffe TW
Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
[TBL] [Abstract][Full Text] [Related]
38. Sulfated polysaccharide heparin used as carrier to load hydrophobic lappaconitine.
Sun W; Saldaña MD; Fan L; Zhao Y; Dong T; Jin Y; Zhang J
Int J Biol Macromol; 2016 Mar; 84():275-80. PubMed ID: 26706841
[TBL] [Abstract][Full Text] [Related]
39. Effects of surface charge of low molecular weight heparin-modified cationic liposomes on drug efficacy and toxicity.
Li H; Chen Y; Deng Y; Wang Y; Ke X; Ci T
Drug Dev Ind Pharm; 2017 Jul; 43(7):1163-1172. PubMed ID: 28277844
[TBL] [Abstract][Full Text] [Related]
40. Vesicular carriers for dermal drug delivery.
Sinico C; Fadda AM
Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
